Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

The Role of Mesenchymal Stem Cells for Hemorrhagic Stroke Management

ACTA MEDICA INDONESIANA · Vol. 57 No. 4 (2025)

ISSN
2338-2732, 0125-9326
Terbit
2025-12-23
Penerbit
The Indonesian Society of Internal Medicine
Bahasa
eng
Lisensi
creativecommons.org/licenses/by/4.0

Abstrak

Stroke is ranked as the second-leading cause of death worldwide. As a result, the long-term sequelae of motor and cognitive abnormalities, such as hemiparesis, paralysis, psychomotor, chronic pain, and behavioral symptoms, can delay the patient's full recovery and function in society. In this context, stem cell-based treatment for stroke has been proven effective due to the potential to provide neurorestorative benefits. This study presented a case of a 50-year-old patient admitted to Cipto Mangunkusumo National General Hospital, Jakarta, in 2022 with intracerebral hemorrhage in the left thalamus, surrounding perifocal edema, and left lateral intraventricular hemorrhage. The patient was given mesenchymal stem cells (MSCs) treatment three times through Digital Subtraction Angiography (DSA). The patient achieved good outcomes in terms of body mobility, balance, and voluntary movement of the upper and lower right limbs.

Kata kunci

Jaringan kolaborasi para penulis

26 penulis · 82 tautan kepenulisan bersama

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Teknologi Sumbawa
  • National Research and Innovation Agency
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Ahmad Sulaiman AlwahdyAfiliasi tidak diketahui2
Berry JuliandiAfiliasi tidak diketahui2
Puspita Eka WuyungAfiliasi tidak diketahui2
Yayi Dwina Bilianti SusantoAfiliasi tidak diketahui2
Irsan HasanAfiliasi tidak diketahui1
Felix F WidjajaAfiliasi tidak diketahui1
Paramita KhairanAfiliasi tidak diketahui1
Lisnawati LisnawatiUniversitas Teknologi Sumbawa1
Cosphiadi IrawanAfiliasi tidak diketahui1
Rahmat CahyanurAfiliasi tidak diketahui1
Murdani AbdullahAfiliasi tidak diketahui1
Siti SetiatiAfiliasi tidak diketahui1
Cleopas Martin RumendeAfiliasi tidak diketahui1
Vally WulaniAfiliasi tidak diketahui1
Eric Daniel TendaAfiliasi tidak diketahui1
Moses Mazmur AsafAfiliasi tidak diketahui1
Mira YuliantiNational Research and Innovation Agency1
Wita SeptiyantiAfiliasi tidak diketahui1
Ceva Wicaksono PitoyoAfiliasi tidak diketahui1
Lukman Hakim MakmunAfiliasi tidak diketahui1
Lukman H MakmunAfiliasi tidak diketahui1
Prasandhya Astagiri YusufAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://www.actamedindones.org/index.php/ijim/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 8 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The Role of Mesenchymal Stem Cells for Hemorrhagic Stroke Management</dc:title>
	<dc:creator>Kurniawan, Mohammad</dc:creator>
	<dc:creator>Kamelia, Telly</dc:creator>
	<dc:creator>Ramli, Yetty</dc:creator>
	<dc:creator>Yunus, Reyhan Eddy</dc:creator>
	<dc:subject xml:lang="en-US">Mesenchymal stem cells</dc:subject>
	<dc:subject xml:lang="en-US">Hemorrhagic Stroke</dc:subject>
	<dc:subject xml:lang="en-US">Digital Subtraction Angiography</dc:subject>
	<dc:description xml:lang="en-US">Stroke is ranked as the second-leading cause of death worldwide. As a result, the long-term sequelae of motor and cognitive abnormalities, such as hemiparesis, paralysis, psychomotor, chronic pain, and behavioral symptoms, can delay the patient's full recovery and function in society. In this context, stem cell-based treatment for stroke has been proven effective due to the potential to provide neurorestorative benefits. This study presented a case of a 50-year-old patient admitted to Cipto Mangunkusumo National General Hospital, Jakarta, in 2022 with intracerebral hemorrhage in the left thalamus, surrounding perifocal edema, and left lateral intraventricular hemorrhage. The patient was given mesenchymal stem cells (MSCs) treatment three times through Digital Subtraction Angiography (DSA). The patient achieved good outcomes in terms of body mobility, balance, and voluntary movement of the upper and lower right limbs.</dc:description>
	<dc:publisher xml:lang="en-US">The Indonesian Society of Internal Medicine</dc:publisher>
	<dc:date>2025-12-23</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>http://www.actamedindones.org/index.php/ijim/article/view/2982</dc:identifier>
	<dc:source xml:lang="en-US">Acta Medica Indonesiana; Vol. 57 No. 4 (2025): Acta Medica Indonesiana; 514</dc:source>
	<dc:source>2338-2732</dc:source>
	<dc:source>0125-9326</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>http://www.actamedindones.org/index.php/ijim/article/view/2982/835</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2025 Telly Kamelia</dc:rights>
	<dc:rights xml:lang="en-US">https://creativecommons.org/licenses/by/4.0</dc:rights>
</oai_dc:dc>